A NEW WAY TO MANAGE TYPE 2 DIABETES THAT ELIMINATES INSULIN INJECTIONS FOR MILLIONS OF AMERICANS
Diabetes management has taken a significant step forward following FDA clearance of the Omnipod 5 Automated Insulin Delivery (AID) System, for adults 18+ living with type 2 diabetes, making it the first and only AID system cleared for the treatment of both type 1 and type 2 diabetes.

Over 30 million Americans live with type 2 diabetes in the United States, with approximately 6 million people who require insulin, of which 2.5 million are using multiple daily injections (MDI). Despite advances in medical therapy over the past 20 years, there has been no significant change in the percentage of adults with type 2 diabetes achieving recommended HbA1c targets.

This clearance is a FIRST in type 2 diabetes management as it:

replaces the exhausting daily routine of multiple daily injections (MDI) with a discreet, tubeless, waterproof5, and wearable “Pod” ― about half the size of a credit card ― which provides continuous insulin delivery for up to 3 days (72 hours)

proactively helps correct for highs ― and helps protect against lows ― both day and night

communicates with a compatible continuous glucose monitor (CGM)

automatically adjusts insulin delivery every 5 minutes using the CGM value and trend

has shown improvements in patient-reported diabetes related distress

Omnipod 5 is a first-of-its-kind, simplified and effective option for people with type 1 and type 2 diabetes, providing freedom from multiple daily injections.
Dr. Trang Ly, Senior Vice President and Chief Medical Officer, Insulet Corporation, will be available to discuss the new automated insulin delivery system for type 2 diabetes and the profound patient impact.
Interview courtesy: Insulet Corporation

#diabetes #dailyinjections #drtrangly #omnipod

The post New & Easier Way to Manage Diabetes-Eliminates Daily Injections appeared first on Good News!.

Type 1 diabetes can’t be prevented or cured. However, it can be detected early through autoantibody screening before any noticeable symptoms arise, before insulin is required, and potentially before any serious complications occur. One such complication is diabetic ketoacidosis (DKA), a serious healthcare crisis that can be life-threatening. Early screening may help people potentially reduce their risk of going through DKA by up to 50%.

There’s a powerful social movement underway called “The 1 Pledge” that includes diverse voices of the type 1 diabetes community. The goal of the movement is to take action and get screened. Anyone can be screened for type 1 diabetes-related autoantibodies. By getting screened for type 1 diabetes early, people may give themselves and their families more time to prepare and plan for the future.

In an effort to spread the word about The 1 Pledge movement and the importance of screening for type 1 diabetes ahead of April 15 (Type 1 Diabetes Day), we invite you to join Dr. Michael B. Natter – a leading, New York-based Endocrinologist (who specializes in treating people with diabetes)

Dr. Natter has type 1 diabetes himself, having been diagnosed at age nine. Dr. Natter will discuss risk factors for type 1 diabetes and who should get screened. He will also talk about The 1 Pledge and the power of creating a plan of action to get screened, from his perspective as both a healthcare provider and a person living with type 1 diabetes.

Interview is courtesy: Sanofi

#diabetes #disease #screenfortype1 #thepledge #sanofi #type1 #insulin #diabetic #therapy #lifelongtherapy #ipledge #the1pledge #families #endocrinologist #diaagnosed #healthcare

The post TYPE 1 DIABETES IS ON THE RISE IN THIS COUNTRY. CURRENTLY, ABOUT 1.24 MILLION AMERICANS LIVE WITH THE DISEASE, AND THAT NUMBER IS EXPECTED TO GROW TO FIVE MILLION BY 2050… appeared first on Good News!.